| | | | | | Präparat | Packungsgrösse | EFP | PP | SB | TK | Zusammensetzung | Zulassungsinhaber | Kat. | | | | |
|---|
|
| Oktober 2022 - 58 Präparate |
|
| | | FI | | | Pretuval Halsschmerzen | 16 | PA | PA | k.A. | | Lutschtabletten mit Honig-Orangenaroma: Benzydamini Hydrochloridum 3 mg | Bayer (Schweiz) AG | D | FB | | G |  |
| | | FI | | | Pretuval Halsschmerzen | 16 | PA | PA | k.A. | | Lutschtabletten mit Zitronenaroma: Benzydamini Hydrochloridum 3 mg | Bayer (Schweiz) AG | D | FB | | G | |
| L | | FI | | | Cabazitaxel-Teva 60 mg/6 ml | | 2447.84 | 2690.90 | 10% | | Infusionskonzentrat: Cabazitaxelum 60mg / 6ml | Teva Pharma AG | A / SL / SG | FB | | G | |
| L | | FI | PI | | Rivaroxaban Sandoz
vascular 2,5 mg | 56 | 28.70 | 47.65 | 10% | | Filmtabletten: Rivaroxabanum 2.5 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| L | | FI | PI | | Rivaroxaban Sandoz
vascular 2,5 mg | 196 | 100.46 | 125.65 | 10% | | Filmtabletten: Rivaroxabanum 2.5 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| L | | FI | PI | CM | Vildagliptin Sandoz 50 mg | 28 | 10.45 | 27.80 | 10% | | Tabletten: Vildagliptinum 50 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| L | | FI | PI | CM | Vildagliptin Sandoz 50 mg | 112 | 41.80 | 61.90 | 10% | | Tabletten: Vildagliptinum 50 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| L | | FI | | | Decitabin Accord 50 mg | | 799.83 | 886.30 | 10% | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Decitabinum 50 mg | Accord Healthcare AG | ● A / SL / SG | FB | | G | |
| L | | FI | | | Decitabin Sandoz 50 mg | | 799.83 | 886.30 | 10% | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Decitabinum 50 mg | Sandoz
Pharmaceuticals AG | A / SL / SG | FB | | G | |
| | | FI | PI | | Vantobra 170 mg | 56 | 2041.44 | 2236.60 | 10% | | Inhalationslösung: Tobramycinum 170mg / 1.7ml | PARI Swiss AG | A / SL | FB | | G | |
| L | | FI | | I/B | MenQuadfi | | 41.15 | 61.15 | 10% | | Injektionslösung: 4 Wirkstoffe | Sanofi-Aventis
(Suisse) SA | B / SL | FB | | G | |
| L | | FI | PI | | Bimzelx 160 mg | 2 | 1950.86 | 2138.10 | 10% | | Injektionslösung in Fertigspritze: Bimekizumabum 160mg / 1ml | UCB-Pharma SA | B / SL | FB | | G | |
| L | | FI | | | Vitamin D3 Sandoz eco
1000 I.E. | 30 | 1.68 | 3.10 | 10% | | Weichkapseln: Cholecalciferolum 1000 UI | Sandoz
Pharmaceuticals AG | D / SL | FB | | G | |
| L | | FI | | | Vitamin D3 Sandoz eco
1000 I.E. | 90 | 5.04 | 9.30 | 10% | | Weichkapseln: Cholecalciferolum 1000 UI | Sandoz
Pharmaceuticals AG | D / SL | FB | | G | |
| L | | FI | | | Vitamin D3 Sandoz eco
3200 I.E. | 30 | 5.38 | 15.10 | 10% | | Weichkapseln: Cholecalciferolum 3200 UI | Sandoz
Pharmaceuticals AG | B / SL | FB | | G | |
| L | | FI | | | Vitamin D3 Sandoz eco
3200 I.E. | 90 | 16.13 | 33.95 | 10% | | Weichkapseln: Cholecalciferolum 3200 UI | Sandoz
Pharmaceuticals AG | ● B / SL | FB | | G | |
| L | | FI | | | Vitamin D3 Sandoz eco
25000 I.E. | 4 | 5.60 | 15.30 | 10% | | Weichkapseln: Cholecalciferolum 25000 UI | Sandoz
Pharmaceuticals AG | B / SL | FB | | G | |
| L | | FI | PI | | Bimzelx 160 mg | 2 | 1950.86 | 2138.10 | 10% | | solution injectable en seringue préremplie: Bimekizumabum 160mg / 1ml | UCB-Pharma SA | B / SL | FB | | G | |
| | | FI | PI | I/B | Comirnaty®
Original/Omicron BA.1
15/15 µg pro Dosis
gebrauchsfertige
Injektionsdispersion für
Personen ab 18 Jahren | 10 | PA | PA | k.A. | | 2 Wirkstoffe | Pfizer AG | B | FB | | G | |
| | | FI | PI | I/B | Comirnaty®
Original/Omicron BA.1
15/15 µg pro Dosis
gebrauchsfertige
Injektionsdispersion für
Personen ab 18 Jahren | 195 | PA | PA | k.A. | | 2 Wirkstoffe | Pfizer AG | B | FB | | G | |
| | | FI | PI | | Bimzelx 160 mg | | PA | PA | k.A. | | Injektionslösung in Fertigspritze: Bimekizumabum 160mg / 1ml | UCB-Pharma SA | B | FB | | G | |
| | | FI | | | Dexmedetomidine Baxter 200
μg/2 ml | 5 | PA | PA | k.A. | | Infusionskonzentrat: Dexmedetomidinum 200µg / 2ml | Baxter AG | A | FB | | G | |
| | | FI | | | Rapibloc 300 mg | | PA | PA | k.A. | | Lyophilisat: Landiololi Hydrochloridum 300 mg | OrPha Swiss GmbH | B | FB | | G | |
| | | FI | PI | | Rivaroxaban Sandoz
vascular 2,5 mg | 10 | PA | PA | k.A. | | Filmtabletten: Rivaroxabanum 2.5 mg | Sandoz
Pharmaceuticals AG | B | FB | | G | |
| | | FI | PI | | Rivaroxaban Sandoz
vascular 2,5 mg | 30 | PA | PA | k.A. | | Filmtabletten: Rivaroxabanum 2.5 mg | Sandoz
Pharmaceuticals AG | B | FB | | G | |
| | | FI | PI | | Rivaroxaban Sandoz
vascular 2,5 mg | 100 | PA | PA | k.A. | | Filmtabletten: Rivaroxabanum 2.5 mg | Sandoz
Pharmaceuticals AG | B | FB | | G | |
| | | | | | Sitagliptin Xiromed 25 mg | 28 | PA | PA | k.A. | | Filmtabletten: Sitagliptinum 25 mg | Xiromed SA | B | FB | | G | |
| | | | | | Sitagliptin Xiromed 25 mg | 98 | PA | PA | k.A. | | Filmtabletten: Sitagliptinum 25 mg | Xiromed SA | B | FB | | G | |
| | | | | | Sitagliptin Xiromed 25 mg | 100 | PA | PA | k.A. | | Filmtabletten: Sitagliptinum 25 mg | Xiromed SA | B | FB | | G | |
| | | | | | Sitagliptin Xiromed 50 mg | 28 | PA | PA | k.A. | | Filmtabletten: Sitagliptinum 50 mg | Xiromed SA | B | FB | | G | |
| | | | | | Sitagliptin Xiromed 50 mg | 98 | PA | PA | k.A. | | Filmtabletten: Sitagliptinum 50 mg | Xiromed SA | B | FB | | G | |
| | | | | | Sitagliptin Xiromed 50 mg | 100 | PA | PA | k.A. | | Filmtabletten: Sitagliptinum 50 mg | Xiromed SA | B | FB | | G | |
| | | | | | Sitagliptin Xiromed 100 mg | 28 | PA | PA | k.A. | | Filmtabletten: Sitagliptinum 100 mg | Xiromed SA | B | FB | | G | |
| | | | | | Sitagliptin Xiromed 100 mg | 98 | PA | PA | k.A. | | Filmtabletten: Sitagliptinum 100 mg | Xiromed SA | B | FB | | G | |
| | | | | | Sitagliptin Xiromed 100 mg | 100 | PA | PA | k.A. | | Filmtabletten: Sitagliptinum 100 mg | Xiromed SA | B | FB | | G | |
| | | FI | | | Vitamin D3 Sandoz eco
25000 I.E. | 8 | PA | PA | k.A. | | Weichkapseln: Cholecalciferolum 25000 UI | Sandoz
Pharmaceuticals AG | B | FB | | G | |
| | | FI | | | Vitamin D3 Sandoz eco
25000 I.E. | 12 | PA | PA | k.A. | | Weichkapseln: Cholecalciferolum 25000 UI | Sandoz
Pharmaceuticals AG | B | FB | | G | |
| | | | | | Klostergarten Brusttee
Hieronymus N | 20 x 1.5 g | PA | PA | k.A. | | Arzneitee: 6 Wirkstoffe | Migros-
Genossenschafts-Bund | E | FB | | G | |
| | | FI | | | Pretuval Halsschmerzen | 20 | PA | PA | k.A. | | Lutschtabletten mit Honig-Orangenaroma: Benzydamini Hydrochloridum 3 mg | Bayer (Schweiz) AG | D | FB | | G | |
| | | FI | | | Pretuval Halsschmerzen | 20 | PA | PA | k.A. | | Lutschtabletten mit Zitronenaroma: Benzydamini Hydrochloridum 3 mg | Bayer (Schweiz) AG | D | FB | | G | |
| | | FI | | | Decitabine Ideogen 50 mg | | PA | PA | k.A. | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Decitabinum 50 mg | Ideogen AG | A | FB | | G | |
| | | | | | abnobaVISCUM Fraxini 0,02 mg | 8 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Visci albi Fraxini Herbae Recentis Extractum Liquidum (Viscum Album ssp. Album l., Herba; Wirtsbaum: Fraxinus Excelsior l., Fraxinus Angustifolia vahl oder ihre Hybriden) | Future Health Pharma
GmbH | A | FB | | G | |
| | | | | | abnobaVISCUM Fraxini 0,02 mg | 21 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Visci albi Fraxini Herbae Recentis Extractum Liquidum (Viscum Album ssp. Album l., Herba; Wirtsbaum: Fraxinus Excelsior l., Fraxinus Angustifolia vahl oder ihre Hybriden) | Future Health Pharma
GmbH | A | FB | | G | |
| | | | | | abnobaVISCUM Fraxini 0,02 mg | 48 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Visci albi Fraxini Herbae Recentis Extractum Liquidum (Viscum Album ssp. Album l., Herba; Wirtsbaum: Fraxinus Excelsior l., Fraxinus Angustifolia vahl oder ihre Hybriden) | Future Health Pharma
GmbH | A | FB | | G | |
| | | | | | abnobaVISCUM Fraxini 0,2 mg | 8 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Visci albi Fraxini Herbae Recentis Extractum Liquidum (Viscum Album ssp. Album l., Herba; Wirtsbaum: Fraxinus Excelsior l., Fraxinus Angustifolia vahl oder ihre Hybriden) | Future Health Pharma
GmbH | A | FB | | G | |
| | | | | | abnobaVISCUM Fraxini 0,2 mg | 21 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Visci albi Fraxini Herbae Recentis Extractum Liquidum (Viscum Album ssp. Album l., Herba; Wirtsbaum: Fraxinus Excelsior l., Fraxinus Angustifolia vahl oder ihre Hybriden) | Future Health Pharma
GmbH | A | FB | | G | |
| | | | | | abnobaVISCUM Fraxini 0,2 mg | 48 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Visci albi Fraxini Herbae Recentis Extractum Liquidum (Viscum Album ssp. Album l., Herba; Wirtsbaum: Fraxinus Excelsior l., Fraxinus Angustifolia vahl oder ihre Hybriden) | Future Health Pharma
GmbH | A | FB | | G | |
| | | | | | abnobaVISCUM Fraxini 2 mg | 8 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Visci albi Fraxini Herbae Recentis Extractum Liquidum (Viscum Album ssp. Album l., Herba; Wirtsbaum: Fraxinus Excelsior l., Fraxinus Angustifolia vahl oder ihre Hybriden) | Future Health Pharma
GmbH | A | FB | | G | |
| | | | | | abnobaVISCUM Fraxini 2 mg | 21 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Visci albi Fraxini Herbae Recentis Extractum Liquidum (Viscum Album ssp. Album l., Herba; Wirtsbaum: Fraxinus Excelsior l., Fraxinus Angustifolia vahl oder ihre Hybriden) | Future Health Pharma
GmbH | A | FB | | G | |
| | | | | | abnobaVISCUM Fraxini 2 mg | 48 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Visci albi Fraxini Herbae Recentis Extractum Liquidum (Viscum Album ssp. Album l., Herba; Wirtsbaum: Fraxinus Excelsior l., Fraxinus Angustifolia vahl oder ihre Hybriden) | Future Health Pharma
GmbH | A | FB | | G | |
| | | | | | abnobaVISCUM Fraxini 20 mg | 8 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Visci albi Fraxini Herbae Recentis Extractum Liquidum (Viscum Album ssp. Album l., Herba; Wirtsbaum: Fraxinus Excelsior l., Fraxinus Angustifolia vahl oder ihre Hybriden) 1 ml | Future Health Pharma
GmbH | A | FB | | G | |
| | | | | | abnobaVISCUM Fraxini D6 | 8 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Viscum Album Fraxini ex Herba Recente col. D6 (Hab 32) 1 ml | Future Health Pharma
GmbH | A | FB | | G | |
| | | | | | abnobaVISCUM Fraxini D10 | 8 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Viscum Album Fraxini ex Herba Recente col. D10 (Hab 32) 1 ml | Future Health Pharma
GmbH | A | FB | | G | |
| | | | | | abnobaVISCUM Fraxini D20 | 8 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Viscum Album Fraxini ex Herba Recente col. D20 (Hab 32) 1 ml | Future Health Pharma
GmbH | A | FB | | G | |
| | | | | | abnobaVISCUM Fraxini D30 | 8 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Viscum Album Fraxini ex Herba Recente col. D30 (Hab 32) 1 ml | Future Health Pharma
GmbH | A | FB | | G | |
| | | | | | abnobaVISCUM Fraxini 20 mg | 21 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Visci albi Fraxini Herbae Recentis Extractum Liquidum (Viscum Album ssp. Album l., Herba; Wirtsbaum: Fraxinus Excelsior l., Fraxinus Angustifolia vahl oder ihre Hybriden) 1 ml | Future Health Pharma
GmbH | A | FB | | G | |
| | | | | | abnobaVISCUM Fraxini 20 mg | 48 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Visci albi Fraxini Herbae Recentis Extractum Liquidum (Viscum Album ssp. Album l., Herba; Wirtsbaum: Fraxinus Excelsior l., Fraxinus Angustifolia vahl oder ihre Hybriden) 1 ml | Future Health Pharma
GmbH | A | FB | | G | |
| | | FI | PI | | Bimzelx 160 mg | | PA | PA | k.A. | | solution injectable en seringue préremplie: Bimekizumabum 160mg / 1ml | UCB-Pharma SA | B | FB | | G | |
